Last Name


TitleAssistant Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Pediatrics
Address1102 Bates St., C750
Houston TX 77030
vCardDownload vCard

    Collapse Additional Tools and Researcher Information 
    Collapse Faculty Mentor
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Moreno-Smith M, Lakoma A, Chen Z, Tao L, Scorsone KA, Schild L, Aviles-Padilla K, Nikzad R, Zhang Y, Chakraborty R, Molenaar JJ, Vasudevan S, Sheehan V, Kim ES, Paust S, Shohet JM, Barbieri E. p53 non-genotoxic activation and mTORC1 inhibition lead to effective combination for neuroblastoma therapy. Clin Cancer Res. 2017 Aug 18. PMID: 28821555.
      View in: PubMed
    2. Van Goethem A, Yigit N, Moreno-Smith M, Vasudevan SA, Barbieri E, Speleman F, Shohet J, Vandesompele J, Van Maerken T. Dual targeting of MDM2 and BCL2 as a therapeutic strategy in neuroblastoma. Oncotarget. 2017 Aug 22; 8(34):57047-57057. PMID: 28915653.
      View in: PubMed
    3. Van Goethem A, Yigit N, Everaert C, Moreno-Smith M, Mus LM, Barbieri E, Speleman F, Mestdagh P, Shohet J, Van Maerken T, Vandesompele J. Depletion of tRNA-halves enables effective small RNA sequencing of low-input murine serum samples. Sci Rep. 2016 Nov 30; 6:37876. PMID: 27901112.
      View in: PubMed
    4. Lakoma A, Barbieri E, Agarwal S, Jackson J, Chen Z, Kim Y, McVay M, Shohet JM, Kim ES. The MDM2 small-molecule inhibitor RG7388 leads to potent tumor inhibition in p53 wild-type neuroblastoma. Cell Death Discov. 2015; 1. PMID: 26998348.
      View in: PubMed
    5. Shi Y, Ma IT, Patel RH, Shang X, Chen Z, Zhao Y, Cheng J, Fan Y, Rojas Y, Barbieri E, Chen Z, Yu Y, Jin J, Kim ES, Shohet JM, Vasudevan SA, Yang J. NSC-87877 inhibits DUSP26 function in neuroblastoma resulting in p53-mediated apoptosis. Cell Death Dis. 2015; 6:e1841. PMID: 26247726.
      View in: PubMed
    6. Barbieri E, De Preter K, Capasso M, Chen Z, Hsu DM, Tonini GP, Lefever S, Hicks J, Versteeg R, Pession A, Speleman F, Kim ES, Shohet JM. Histone chaperone CHAF1A inhibits differentiation and promotes aggressive neuroblastoma. Cancer Res. 2014 Feb 1; 74(3):765-74. PMID: 24335960.
      View in: PubMed
    7. Barbieri E, De Preter K, Capasso M, Johansson P, Man TK, Chen Z, Stowers P, Tonini GP, Speleman F, Shohet JM. A p53 drug response signature identifies prognostic genes in high-risk neuroblastoma. PLoS One. 2013; 8(11):e79843. PMID: 24348903; PMCID: PMC3865347.
    8. Hsu DM, Agarwal S, Benham A, Coarfa C, Trahan DN, Chen Z, Stowers PN, Courtney AN, Lakoma A, Barbieri E, Metelitsa LS, Gunaratne P, Kim ES, Shohet JM. G-CSF receptor positive neuroblastoma subpopulations are enriched in chemotherapy-resistant or relapsed tumors and are highly tumorigenic. Cancer Res. 2013 Jul 1; 73(13):4134-46. PMID: 23687340; PMCID: PMC4298227.
    9. Shohet JM, Ghosh R, Coarfa C, Ludwig A, Benham AL, Chen Z, Patterson DM, Barbieri E, Mestdagh P, Sikorski DN, Milosavljevic A, Kim ES, Gunaratne PH. A genome-wide search for promoters that respond to increased MYCN reveals both new oncogenic and tumor suppressor microRNAs associated with aggressive neuroblastoma. Cancer Res. 2011 Jun 1; 71(11):3841-51. PMID: 21498633.
      View in: PubMed
    10. Patterson DM, Gao D, Trahan DN, Johnson BA, Ludwig A, Barbieri E, Chen Z, Diaz-Miron J, Vassilev L, Shohet JM, Kim ES. Effect of MDM2 and vascular endothelial growth factor inhibition on tumor angiogenesis and metastasis in neuroblastoma. Angiogenesis. 2011 Sep; 14(3):255-66. PMID: 21484514.
      View in: PubMed
    11. Chen Z, Lin Y, Barbieri E, Burlingame S, Hicks J, Ludwig A, Shohet JM. Mdm2 deficiency suppresses MYCN-Driven neuroblastoma tumorigenesis in vivo. Neoplasia. 2009 Aug; 11(8):753-62. PMID: 19649205; PMCID: PMC2713395.
    12. Barbieri E, Mehta P, Chen Z, Zhang L, Slack A, Berg S, Shohet JM. MDM2 inhibition sensitizes neuroblastoma to chemotherapy-induced apoptotic cell death. Mol Cancer Ther. 2006 Sep; 5(9):2358-65. PMID: 16985070.
      View in: PubMed
    13. Pession A, Barbieri E. Treatment and prevention of tumor lysis syndrome in children. Experience of Associazione Italiana Ematologia Oncologia Pediatrica. Contrib Nephrol. 2005; 147:80-92. PMID: 15604608.
      View in: PubMed
    14. Pession A, Barbieri E, Santoro N, Paolucci P, Porta F, Locatelli F. Efficacy and safety of recombinant urate oxidase (rasburicase) for treatment and prophylaxis of hyperuricemia in children undergoing chemotherapy. Haematologica. 2005 Jan; 90(1):141-2. PMID: 15642687.
      View in: PubMed
    15. Cicognani A, Pasini A, Pession A, Pirazzoli P, Burnelli R, Barbieri E, Mazzanti L, Cacciari E. Gonadal function and pubertal development after treatment of a childhood malignancy. J Pediatr Endocrinol Metab. 2003 Mar; 16 Suppl 2:321-6. PMID: 12729411.
      View in: PubMed
    16. Cicognani A, Alessandroni R, Pasini A, Pirazzoli P, Cassio A, Barbieri E, Cacciari E. Low birth weight for gestational age and subsequent male gonadal function. J Pediatr. 2002 Sep; 141(3):376-9. PMID: 12219058.
      View in: PubMed
    17. Salardi S, Zucchini S, Cicognani A, Gualandi S, Barbieri E, Cacciari E. Inhibin B levels in adolescents and young adults with type 1 diabetes. Horm Res. 2002; 57(5-6):205-8. PMID: 12053095.
      View in: PubMed
    18. Zucchini S, Cacciari E, Balsamo A, Cicognani A, Tassinari D, Barbieri E, Gualandi S. Final height of short subjects of low birth weight with and without growth hormone treatment. Arch Dis Child. 2001 Apr; 84(4):340-3. PMID: 11259236; PMCID: PMC1718724.
    BARBIERI's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    Co-Authors Expand Description
    Similar People Expand Description
    Physical Neighbors Expand Description